Gloucestershire Royal Hospital is an acute District General Hospital on the Great Western Road in Gloucester operated by the Gloucestershire Hospitals NHS Foundation Trust.

There are 683 beds in Gloucestershire Royal Hospital.

During the past decade, Gloucestershire Royal Hospital conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 12 clinical trials were completed, i.e. on average, 24% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 12 clinical trials were completed. i.e. 54.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gloucestershire Royal Hospital" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "University College, London" with 4 trials sponsored, "Gloucestershire Hospitals NHS Foundation Trust" with 2 trials sponsored and "Imperial College London" with 2 trials sponsored. Other sponsors include 43 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gloucestershire Royal Hospital" #1 collaborator was "Cancer Research UK" with 6 trials as a collaborator, "Gloucestershire Hospitals NHS Foundation Trust" with 4 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 2 trials as a collaborator and "Takeda" with 2 trials as a collaborator. Other collaborators include 79 different institutions and companies that were collaborators in the rest 88 trials.

According to Clinical.Site data, the most researched conditions in "Gloucestershire Royal Hospital" are "Diabetic Macular Edema" (6 trials), "Lymphoma" (4 trials), "Atrial Fibrillation" (3 trials), "Head and Neck Cancer" (3 trials) and "Primary Myelofibrosis" (3 trials). Many other conditions were trialed in "Gloucestershire Royal Hospital" in a lesser frequency.

Most popular intervention types in "Gloucestershire Royal Hospital" are "Drug" (51 trials), "Other" (14 trials), "Procedure" (13 trials), "Diagnostic Test" (5 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (7 trials), "Faricimab" (6 trials), "Placebo" (5 trials), "quality-of-life assessment" (4 trials) and "Aflibercept" (3 trials). Other intervention names were less common.

The vast majority of trials in "Gloucestershire Royal Hospital" are 65 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Gloucestershire Royal Hospital". 1 are not yet recruiting, 16 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Gloucestershire Royal Hospital, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Gloucestershire Royal Hospital, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 10 trials that are defined as “Not Applicable".

Gloucestershire Royal Hospital has several departments that took part in Clinical trials: "Gloucestershire Oncology Centre at Cheltenham General Hospital" - 26 trials